I thought that one of the primary unknowns back in March was the question that lower dosages of the drug could be effective.
Since it appears to work at the 200mg level, this should be somewhat of a positive for the stock no? Or AT AN ABSOLUTE MINIMUM, STOP THE CARNAGE OF SELLING